Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Patient Information Leaflet last updated on the eMC: 20/01/2012
PIL Puregon 100 IU/0.5 ml solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to manufacturer contact details
  • Change to MA holder contact details
Updated on 18/10/2011 and displayed until 20/01/2012
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 18/01/2011 and displayed until 18/10/2011
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 08/12/2010 and displayed until 18/01/2011
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 24/02/2010 and displayed until 08/12/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 27/09/2007 and displayed until 24/02/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 14/12/2006 and displayed until 27/09/2007
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 12/12/2006 and displayed until 14/12/2006
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 05/03/2003 and displayed until 12/12/2006
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   follitropin beta